Lincomed 300

Lincomed 300

Lincomed 300 Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Human Warnings:  Not for human use.  Keep out of reach of children.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

INDICATIONS FOR SWINE:

LincoMed® 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity.  This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.

It is also indicated for the treatment of mycoplasma pneumonia.

History

There is currently no drug history available for this drug.

Other Information

LincoMed® 300

lincomycin injection, USP
Swine Antibiotic

Restricted Drug (California) - Use only as Directed.

For Use in Animals Only

ANADA 200-368, Approved by FDA

Net Content: 100ml (3.3 fl oz)

For use in swine weighing 300 pounds or more.

For Intramuscular Use in Swine Only

DESCRIPTION:

LincoMed® 300 contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.

Lincomed 300 Manufacturers


  • Bimeda Inc., Animal Health, Division Of Cross Vetpharm Group
    Lincomed 300 (Lincomycin) Injection [Bimeda Inc., Animal Health, Division Of Cross Vetpharm Group]

Login To Your Free Account